Advanced search
Publication Cover
Clinical Toxicology Volume 55, 2017 - Issue 9
Submit an article Journal homepage
394
Views
12
CrossRef citations to date
0
Altmetric
Short Communication

Acute cholinergic syndrome in a patient with mild Alzheimer’s type dementia who had applied a large number of rivastigmine transdermal patches on her body

Yoshiki SuzukiEmergency Medical Center and Poison Center, Saitama Medical University Hospital, Saitama, Japan; ;Department of Pharmacy, Saitama Medical University Hospital, Saitama, Japan;
,
Yoshito KamijoEmergency Medical Center and Poison Center, Saitama Medical University Hospital, Saitama, Japan; Correspondence[email protected]
,
Tomohiro YoshizawaEmergency Medical Center and Poison Center, Saitama Medical University Hospital, Saitama, Japan; ;Department of Pharmacy, Saitama Medical University Hospital, Saitama, Japan;
,
Yuji FujitaDepartment of Emergency, Disaster and General Medicine, Iwate Medical University School of Medicine, Iwate, Japan;
,
Kiyotaka UsuiDepartment of Forensic Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan
&
Tohru KishinoDepartment of Pharmacy, Saitama Medical University Hospital, Saitama, Japan;
Pages 1008-1010 | Received 13 Jan 2017, Accepted 07 May 2017, Published online: 08 Jun 2017

References

  • Corey-Bloom J, Anand R, Veach J, et al. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to slightly severe Alzheimer’s disease. Int J Geriatr Psychopharmacol. 1998;1:55–65.
  • Cutler NR, Polinsky RJ, Sramek JJ, et al. Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease. Acta Neurol Scand. 1998;97:244–250.
  • Lefevre G, Sedek G, Jhee SS, et al. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients. Clin Pharmacol Ther. 2008;83:106–114.
  • Lefevre G, Sedek G, Huang HL, et al. Pharmacokinetics of a rivastigmine transdermal patch formulation in healthy volunteers: relative effects of body site application. J Clin Pharmacol. 2007;47:471–478.
  • Lee DH, Choi YH, Cho KH, et al. A case of rivastigmine toxicity caused by transdermal patch. Am J Emerg Med. 2011;29:695.e1–695.e2.
  • Lovborg H, Jonsson AK, Hagg S. A fatal outcome after unintentional overdosing of rivastigmine patches. Curr Drug Saf. 2012;7:30–32.
  • Hoffman RS, Manini AF, Russell-Haders AL, et al. Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity. Hum Exp Toxicol. 2009;28:599–602.
  • Singh S, Bhardwaj U, Verma SK, et al. Hyperamylasemia and acute pancreatitis following anticholinesterase poisoning. Hum Exp Toxicol. 2007;26:467–471.
  • Polinsky RJ. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin Ther. 1998;20:634–647.
  • Pinakini KS, Kumar TS. Serial cholinesterase estimation in carbamate poisoning. J Clin Forensic Med. 2006;13:274–276.
  • Abdullat IM, Battah AH, Hadidi KA. The use of serial measurement of plasma cholinesterase in the management of acute poisoning with organophosphates and carbamates. Forensic Sci Int. 2006;162:126–130.
  • Spencer CM, Noble S. Rivastigmine. A review of its use in Alzheimer's disease. Drugs Aging. 1998;13:391–411.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.